FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On November 27, 2006
Docket # Title
1978N-0065 Skin Bleaching Drug Products
1999D-4114 Testing for Replication Competent Retrovirus in Retroviral
2003N-0312 Discussion of Animal Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program for the Manufacture and Distribution of Animal Feeds
2005H-0271 Civil Money Penalty: TMJ Implants, Inc.
2005N-0403 Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
2006D-0331 Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
2006D-0347 Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
2006D-0383 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
2006F-0409 Safe Use of Cetylpyridinium Chloride as an Antimicrobial Agent in a Pre-chiller or Post-chiller Solution for Application to Raw Poultry Carcasses (FAP 6A4767)
2006M-0473 Paragon Vision Sciences, Premarket Approval for Paragon Z CRT (tisilfocon A) Rigid Gas Permeable Contact Lenses for Contact Lens Corneal Refractive Therapy, P050031
2006N-0352 Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
2006N-0378 Review of Agreements, Guidances, and Practices Specific to Assignment of Combination Products in Compliance with the Medical Device User Fee and Modernization Act of 2002
2006N-0414 Suicidality Data from Adult Antidepressant Trials
2006P-0085 To Exempt the Class II device Cranial Orthoses from Premarket Notification Requirements
2006P-0223 Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
2006P-0390 Order the Church of Scientology to clearly disclose the potential health hazards inherent in the use of the E-meter and Scientology's practice of "auditing"
2006P-0394 Revise the labeling requirements for eggs sold in the United States
1978N-0065 Skin Bleaching Drug Products
C 32 Form Letters Vol #: 16
C 33 Atlanta Center of Dermatology & Medi Spa, PC Vol #: 15
C 34 T. Hopkins Vol #: 15
C 35 Tufts New England Medical Center Vol #: 15
C 36 SkinCare Physicians of Chestnut Hill Vol #: 15
C 37 Center for Dermatology & Cosmetic Surgery Vol #: 15
EC 91 American Society Dermatologic Surgery (ASDS) Vol #: 14
EC 92 Dermatologic Care, Inc. Vol #: 14
EC 93 New England Medical Center Vol #: 14
EC 94 Dr. Mark Rubin Vol #: 14
EC 95 ASDS Vol #: 14
EC 96 Dr. Peter Hallarman Vol #: 14
EC 97 Dr. N. Patrick Hennessey Vol #: 14
EXT 2 Cosmetic, Toiletr, and Fragrance Association (CTFA) Vol #: 15
1999D-4114 Testing for Replication Competent Retrovirus in Retroviral
GDL 3 Supplemental Guidance Vol #: 1
2003N-0312 Discussion of Animal Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program for the Manufacture and Distribution of Animal Feeds
EC 29 Ms. Joan Royal Vol #: 8
2005H-0271 Civil Money Penalty: TMJ Implants, Inc.
EXB 1 Exhibit G 1. Declaration of Gary W. Smagalski, D.D.S., F.A.C.D Vol #: 7
EXB 2 Exhibit G 2. Supplemental Declaration of Gary W. Smagalski, D.D.S, F.A.C.D. Vol #: 7
EXB 3 Exhibit G-3. Declaration of James Q. Swift, D.D.S. Vol #: 7
EXB 4 Exhibit G-4. Supplemental Declaration of James Q. Swift, D.D.S. Vol #: 7
EXB 5 Exhibit G-5. Supplemental Declaration of Howard A. Press Vol #: 7
EXB 6 R-1. Direct testimony Declaration of Robert W. Christensen Vol #: 10
EXB 7 R-2. Direct Testimony Declaration of James T. Curry, DDS Vol #: 11
EXB 8 R-3. Direct Testimony Declaration of Ricardo R. Alexander, DDS Vol #: 12
EXB 9 Exhibit R 4. Direct Testimony Declaration of Maureen K. Mooney Vol #: 13
EXB 10 R-5. Direct Testimony Declaration of Bonnie J. Ray Vol #: 14
EXB 11 R-6. Privilege Log for Documents 00001-4185 Vol #: 15
EXB 12 R-7. Daniel Schultz Privilege Log for Documents 00001-4185 Vol #: 16
EXB 13 R-8. Summary of Duplicate and Near Duplicate Documents Vol #: 17
EXB 14 R-9 Priveldge Log for Documents 4848-4950 Vol #: 18
EXB 15 R-10. OC and OSB Agreement Vol #: 19
EXB 16 R-11. Memo of Understanding Related to Medical Device Reporting Vol #: 20
EXB 17 R-12. Supervisory Interdiciplinary Scientist Job Description Vol #: 21
EXB 18 R-13. Deborah Yodar CV Vol #: 22
EXB 19 R-14. Nurse Consultant Job Description Vol #: 23
EXB 20 R-15 Janie G. Fuller CV Vol #: 24
EXB 21 R-16 Director Regulatory Review Officer Job Description Vol #: 25
EXB 22 R-17 David Steven Shindell CV Vol #: 26
EXB 23 R-18 Supervisory Consumer Safety Officer Job Description Vol #: 27
EXB 24 R-19 Chester T. Reynolds CV Vol #: 28
EXB 25 R-20 Public Health Advisor Job Description Vol #: 29
EXB 26 R-21 Brenda Sanderson Lucas, RN CV Vol #: 30
EXB 27 R-22 Nurse Consultant Job Description Vol #: 31
EXB 28 R-23 Email (Bate stamp 0109) Vol #: 32
EXB 29 R-24 Email (Bate stamp 0110) Vol #: 33
EXB 30 R-25 Email (Bate stamp 0112) Vol #: 34
EXB 31 R-26 Email (Bate stamp 0113) Vol #: 35
EXB 32 R-27 Email (Bate stamp 0114) Vol #: 36
EXB 33 R-28 Email (Bate stamp 0115) Vol #: 37
EXB 34 R-29 Email (Bate stamp 0116) Vol #: 38
EXB 35 R-30 Email (Bate stamp 0118) Vol #: 39
EXB 36 R-31 Email (Bate stamp 0134) Vol #: 40
EXB 37 R-32 Email (Bate stamp 0135) Vol #: 41
EXB 38 R-33 Email (Bate stamp 0136) Vol #: 42
EXB 39 R-34 Email (Bate stamp 0137) Vol #: 43
EXB 40 R-35 Email (Bate stamp 0138) Vol #: 44
EXB 41 R-36 Email (Bate stamp 0533-34) Vol #: 45
EXB 42 R-37 Not Used Vol #: 46
EXB 43 R-38 Email (Bate stamp 1225) Vol #: 47
EXB 44 R-39 Email (Bate stamp 2543) Vol #: 48
EXB 45 R-40 Email (Bate stamp 2544) Vol #: 49
EXB 46 R-41 Standard Operating Procedure 202-001 Complaint Handling Vol #: 50
EXB 47 R-42 Standard Operating Procedure 202-002 Medical Device Reporting Vol #: 51
EXB 48 R-43 Form CO-107 MDR Evaluation Checklist Vol #: 52
EXB 49 R-44 Form CO-005 Complaint Form Vol #: 53
EXB 50 R-45 Form CO-060 Explant Form Vol #: 54
EXB 51 R-46 Label 1-084 Fossa-Eminence Instruction fro Use Vol #: 55
EXB 52 R-47 Label 1-085 TMJ Total Joint Instructions for Use Vol #: 56
LET 3 FDA/CDRH/OGC Vol #: 7
LET 4 TMJ Implants Inc. Vol #: 9
LET 5 TMJ Implants Inc. Vol #: 9
2005N-0403 Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs
C 5 TAP Pharmaceutical Products, Inc. Vol #: 3
C 6 Ranbaxy, Inc. Vol #: 3
C 7 Nelco Laboratories, Inc. Vol #: 3
EC 3 Ben Venue Laboratories, Inc. Vol #: 3
EC 4 Genpharm Inc Vol #: 3
EC 5 Generic Pharmaceutical Association Vol #: 3
EC 6 Taro Pharmaceuticals USA Inc. Vol #: 3
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
C 18213 K. Herceg Vol #: 198
2006D-0331 Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
EC 62 Northfield Laboratories Inc. Vol #: 3
EC 63 National Association of EMS Physicians Vol #: 3
EC 64 Oregon Health & Science University Vol #: 3
EC 65 Law Student Vol #: 3
2006D-0347 Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
EC 11 M. D. Anderson Cancer Center Vol #: 1
2006D-0383 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
C 123 M. Webster Vol #: 9
C 124 W and C YOntz Vol #: 9
C 125 J. Collier Vol #: 9
C 126 J. Kremer Vol #: 9
C 127 M. Brazwell Vol #: 9
C 128 P. Kremer Vol #: 9
C 129 Dr. T. Lisk Vol #: 9
C 130 L. Girit Vol #: 9
C 131 D. Laurens, M.A. Vol #: 9
C 132 K. Kremer Vol #: 9
EC 2077 Mr. William Grothus Vol #: 8
EC 2078 Mrs. Leslye Killian Vol #: 8
EC 2079 Mr. Brion Collins Vol #: 8
EC 2080 St. Mary's Catholic Church Vol #: 8
EC 2081 Mr. Ryan DeCook Vol #: 8
EC 2082 Mrs. Samantha Negri Vol #: 8
EC 2083 Mrs. Dolores Stack Vol #: 8
EC 2084 Mrs. Colleen Jessel Vol #: 8
EC 2085 Mrs. Patricia Griffin Vol #: 8
EC 2086 Dr. Nicole Best Vol #: 8
EC 2087 Ms. Elizabeth Schleck Vol #: 8
EC 2088 Miss. Susan Tesorero Vol #: 8
EC 2089 Mr. Richard Renck Vol #: 8
EC 2090 Mr. Andrew Bloomfield Vol #: 8
EC 2091 Mrs. MARY SCHULTZ, BSN Vol #: 8
EC 2092 Mr. Merton Garrison Vol #: 8
EC 2093 Mr. Noel Ballard Vol #: 8
EC 2094 Mrs. Bridget McLaughlin Vol #: 8
EC 2095 Mrs. Mary Vilim Vol #: 8
EC 2096 Mr. Leonard Kuhar Vol #: 8
EC 2097 Miss. Cassie Boorn Vol #: 8
EC 2098 Mr. Al Riskowski Vol #: 8
EC 2099 Mrs. Toni Collins Vol #: 8
EC 2100 Mrs. Karen Manning Vol #: 8
EC 2101 Mrs. Mary Landis Vol #: 8
EC 2102 Mrs. Carol Peck Vol #: 8
EC 2103 Ms. Sieglinde McGinnis Vol #: 8
EC 2104 none Vol #: 8
EC 2105 Mrs. Marianne Bianco R.D. Vol #: 8
EC 2106 Mr. William Mihalski Vol #: 8
EC 2107 Mr. Ralph Arnsparger Vol #: 8
EC 2108 Mrs. Stacey Freddino Vol #: 8
EC 2109 Ms. Gina Upperman Vol #: 8
EC 2110 Mrs. MaryAnn Hassan Vol #: 8
EC 2111 Mrs. MaryAnn Hassan Vol #: 8
EC 2112 Mrs. Margaret Sackett Vol #: 8
EC 2113 Ms. mary norton Vol #: 8
EC 2114 Mrs. Tracy Sparling Vol #: 8
EC 2115 Mrs. Kathy Naquin Vol #: 8
EC 2116 Mr. David Wilton Vol #: 8
EC 2117 Mrs. Suzan Hudak Vol #: 8
EC 2118 Mr. Greg Johnson Vol #: 8
EC 2119 The Roman Catholic Church Vol #: 8
EC 2120 Mrs. Kimberly Cole Vol #: 8
EC 2121 Mr. Kurtis Gunwall Vol #: 8
EC 2122 Mrs. Clare Kosmalski Vol #: 8
EC 2123 Mrs. H Opiela Vol #: 8
EC 2124 Mrs. Debra Null Vol #: 8
EC 2125 Mrs. Susan A. Crumpton Vol #: 8
EC 2126 Miss. Mary Norick Vol #: 8
EC 2127 Mr. Christopher Vaness Vol #: 8
EC 2128 Mrs. Flavia Vanes Vol #: 8
EC 2129 Dr. Hugh Masterson Vol #: 8
EC 2130 Mr. Robert Jones Vol #: 8
EC 2131 Mrs. michelle hanafee Vol #: 8
EC 2132 Miss. Lydia Jackson Vol #: 8
EC 2133 Mr. Robert J. Awerkamp Vol #: 8
EC 2134 Miss. Mary T. Mashburn Vol #: 8
EC 2135 Mrs. Elaine Best Vol #: 8
EC 2136 Mrs. Barbara Patterson Vol #: 8
EC 2137 Mrs. Rachael Ramirez Vol #: 8
EC 2138 Mrs. Lisa Larson Vol #: 8
EC 2139 Mr. Wayne Tryhuk Vol #: 8
EC 2140 Mr. Patrick Hart Vol #: 8
EC 2141 Mr. Robert Kabat Vol #: 8
EC 2142 Mrs. Linda Heaton Vol #: 8
EC 2143 Ms. Theresa Sedlacek Vol #: 8
EC 2144 Mr. Duane Nelson Vol #: 8
EC 2145 Miss. Victoria Siebert Vol #: 8
EC 2146 Mrs. Nellita Lee Vol #: 8
EC 2147 Mrs. Sandy Bast Vol #: 8
EC 2148 Mrs. Eileen Adams Vol #: 8
EC 2149 Mr. Gary Fallon Vol #: 8
EC 2150 Mrs. Beth Eilers Vol #: 8
EC 2151 Dr. Maurice Faugot Vol #: 8
EC 2152 Mr. Albert and Geraldine Duzenack Vol #: 8
EC 2153 Mrs. victoria sampson Vol #: 8
EC 2154 Mr. Tim Schauf Vol #: 8
EC 2155 Mrs. Martha ODonnell Vol #: 8
EC 2156 Ms. stephanie duez Vol #: 8
EC 2157 Mr. Terrence Brown Vol #: 8
EC 2158 Mrs. Hazel Kliner Vol #: 8
EC 2159 Mrs. Amber Swehla Vol #: 8
EC 2160 Mrs. karen splonskowski Vol #: 8
EC 2161 Mrs. Bernadette Nielsen Vol #: 8
EC 2162 Ms. Mary Rupp Vol #: 8
EC 2163 Mrs. Melissa Przybysz Vol #: 8
EC 2164 Mrs. Penny Montijo Vol #: 8
EC 2165 Ms. cornelia linney Vol #: 8
EC 2166 St. Francis Xavier Parish, St. Joseph, MO Vol #: 8
EC 2167 Mrs. Linda Holman Vol #: 8
EC 2168 Miss. Catherine Perlock Vol #: 8
EC 2169 Mrs. Kathleen Exsted Vol #: 8
EC 2170 Mrs. Donna Slaybaugh Vol #: 8
EC 2171 Mr. Robert Renza Vol #: 8
EC 2172 Mr. Andrew Eells Vol #: 8
EC 2173 Mrs. Valerie Way Vol #: 8
EC 2174 Miss. Mary Mulvaney Vol #: 8
EC 2175 Mrs. Mary Jo Nelson Vol #: 8
EC 2176 Mrs. Kay Capetillo Vol #: 8
EC 2177 Mrs. Claudette Buckley Vol #: 8
EC 2178 Ms. Elizabeth Jacquez Vol #: 8
EC 2179 Mrs. Diane Caldwell Vol #: 8
EC 2180 Mr. Terrence Buckley Vol #: 8
EC 2181 Mrs. Barbara Harburg Vol #: 8
EC 2182 Mrs. Jennifer Ledoux Vol #: 8
EC 2183 Mr. robert paige Vol #: 8
EC 2184 Mr. Paul Harger Vol #: 8
EC 2185 Mrs. Noreen Frey Vol #: 8
EC 2186 Miss. Monica Williams Vol #: 8
EC 2187 Dr. R. Louise Smyth Vol #: 8
EC 2188 Dr. Michael Hoffman Vol #: 8
EC 2189 Mrs. Pam Albrethsen Vol #: 8
EC 2190 Dr. Stanley Kenwood Vol #: 8
EC 2191 Mrs. Laura Huresky Vol #: 8
EC 2192 Mr. Paul Huresky Vol #: 8
EC 2193 Mr. Scott Kumer Vol #: 8
2006F-0409 Safe Use of Cetylpyridinium Chloride as an Antimicrobial Agent in a Pre-chiller or Post-chiller Solution for Application to Raw Poultry Carcasses (FAP 6A4767)
C 2 Ecolab Inc. Vol #: 1
2006M-0473 Paragon Vision Sciences, Premarket Approval for Paragon Z CRT (tisilfocon A) Rigid Gas Permeable Contact Lenses for Contact Lens Corneal Refractive Therapy, P050031
AAV 1 Paragon Vision Sciences Vol #: 1
2006N-0352 Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
C 388 K. Prior Vol #: 26
C 389 N. Gianoli Vol #: 26
C 390 R. Dinkle Vol #: 26
C 391 P. Dodson Vol #: 26
C 392 Dr. K. Chai Vol #: 26
C 393 N. Gianoli Vol #: 26
C 394 D. Watkins Vol #: 26
C 395 C. Griggs Vol #: 26
C 396 B. Yeary Vol #: 26
C 397 E. Krinsky Vol #: 26
C 398 R. Murray Vol #: 26
C 399 M. Kolbay Vol #: 26
C 400 R. Talmadge Vol #: 26
C 401 R. McFerran, D.D.S. Vol #: 26
C 402 K. Fontaine Vol #: 26
C 403 A. Berg Vol #: 26
C 404 Department of the Planet Earth Vol #: 26
C 405 D. Frigo, J.D. Vol #: 26
C 406 K. Sobota Vol #: 26
C 407 C. Magruder Vol #: 26
C 408 K. Ross Vol #: 26
C 409 Dr. B. Dawson, DC Vol #: 26
C 410 J. Tobey Vol #: 26
C 411 C. Otero, M.D. Vol #: 26
C 412 S. Dilks Vol #: 26
C 413 Dr. J. Harrington Vol #: 26
C 414 A. Belcher Vol #: 26
C 415 A. Belcher Vol #: 26
C 416 R. Baritz, DC Vol #: 26
C 417 K. Rusinoski Vol #: 26
C 418 L. Turner Vol #: 26
C 419 C. Santangelo, MD Vol #: 26
C 420 Dr. M. Gordon Vol #: 26
C 421 J. Phelps Vol #: 26
C 422 M. Jacke Vol #: 26
C 423 J. Megalo Vol #: 26
C 424 S. Jones BA, PT, DC Vol #: 26
C 425 R. King, DDS Vol #: 26
C 426 Y. Lu Vol #: 26
C 427 C. Skinner Vol #: 26
C 428 Carolyn Vol #: 26
C 429 Y. Gulezian Vol #: 26
C 430 Pure Water Committee of Western Maryland, Inc. Vol #: 26

C 431 S. Patterson Vol #: 26
C 432 M. Dorazio Vol #: 26
C 433 Dr. L. Hansen Vol #: 26
C 434 T. Hunger Vol #: 26
C 435 R. Volpe Vol #: 26
C 436 K. Dudek Vol #: 26
C 437 N. Campbell Vol #: 26
C 438 P. Das Vol #: 26
C 439 T. Moore Vol #: 26
C 440 U. Bengtsson Vol #: 26
C 441 B. Clark Vol #: 26
C 442 R. Montoya Vol #: 26
C 443 S. Long Vol #: 26
C 444 R. Brown Vol #: 26
C 445 A. Pasche Vol #: 26
C 446 R. Levine Vol #: 26
C 447 No siganture Vol #: 26
C 448 D. Ingalls Vol #: 26
2006N-0378 Review of Agreements, Guidances, and Practices Specific to Assignment of Combination Products in Compliance with the Medical Device User Fee and Modernization Act of 2002
C 1 Wyeth Pharmaceuticals, Inc. Vol #: 1
EC 1 National Electrical Manufacturers Association Vol #: 1
2006N-0414 Suicidality Data from Adult Antidepressant Trials
EC 1 Citizens Commission on Human Rights of St. Louis Vol #: 1
EC 2 CHAADA - www.chaada.org Vol #: 1
EC 3 Mr. Edward Pebley Vol #: 1
EC 4 Ms. Patricia Robinett Vol #: 1
EC 5 Mrs. Debby Paintr Vol #: 1
EC 6 CHAADA Vol #: 1
EC 7 Mrs. Gerry Dunn Vol #: 1
EC 8 MindFreedom Vol #: 1
EC 9 Mrs. Kimberly Osburn Vol #: 1
2006P-0085 To Exempt the Class II device Cranial Orthoses from Premarket Notification Requirements
C 10 Form Letters Vol #: 3
C 11 Form Letters Vol #: 4
C 12 R. Novak, MS CO Vol #: 2
C 13 D. Lima, CO, OTR/L Vol #: 2
C 14 Children's Memorial Hospital Vol #: 2
C 15 Ortho Pro Associates, Inc. Vol #: 2
C 16 Cranial Therapies, Inc. Vol #: 2
C 17 Children Hospital Boston Vol #: 2
EC 12 american society of pediatric neurosurgery Vol #: 2
EC 13 AANS/CNS Forum on Drugs, Devices, and Biologics Vol #: 2
EC 14 Section of Pediatric Neurosurgery, AANS/CNS Vol #: 2
EC 15 Harvard Medical School/Children's Hospital, Boston Vol #: 2
2006P-0223 Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
EC 715 Miss. Jessica Feller Vol #: 5
EC 716 Mr. George Burgess Vol #: 5
2006P-0390 Order the Church of Scientology to clearly disclose the potential health hazards inherent in the use of the E-meter and Scientology's practice of "auditing"
EC 15 Mr. Jerry Staton Vol #: 1
EC 16 Mr. Jerry Staton Vol #: 1
2006P-0394 Revise the labeling requirements for eggs sold in the United States
C 21 Illegible Vol #: 6
EC 417 Miss. Randee Keiver Vol #: 7
EC 418 Miss. Janet Shannon Vol #: 7
EC 419 Mrs. Karen Tracey Vol #: 7
EC 420 Ms. Donna Coughlin Vol #: 7
EC 421 Mrs. April Beresford Vol #: 7
EC 422 Miss. Wynter Miceli Vol #: 7
EC 423 Mr. Drew Meigs Vol #: 7
EC 424 Ms. Amy Torgerson Vol #: 7
EC 425 Mr. Henry Hoecker Vol #: 7
EC 426 COK Vol #: 7

Page created on January 24, 2007 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management